MetaCap

ARS Pharmaceuticals Insider Trades

NASDAQ: SPRYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.23-0.33 (-7.24%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
5 · $1.95M
Shares bought / sold
0 / 216.56K
Net activity
Net selling $1.9 million

ARS Pharmaceuticals insider activity

Over the last 12 months, ARS Pharmaceuticals insiders reported 10 transactions on SEC Form 4: 0 open-market purchases and 5 sales. Insiders bought $0 and sold $1.9 million worth of stock, for net insider selling of $1.9 million. The largest seller was Chakma Justin, with $1.5 million in reported sales.

The most recent filing shows Karas Eric (Chief Commercial Officer) reporting a transaction in 25,000 shares at $1.50 on Jun 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SPRY's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

SPRY insider transactions

ARS Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Jun 12, 2026Fitzpatrick Alexander AChief Legal OfficerSale3,355$33.55KForm 4
Jun 12, 2026Karas EricChief Commercial OfficerSale25,000$250.00KForm 4
Jun 12, 2026Karas EricChief Commercial OfficerOption exercise25,000$37.50KForm 4
Nov 13, 2025Dorsey BrianChief Operating OfficerSale21,828$190.05KForm 4
Nov 13, 2025Dorsey BrianChief Operating OfficerOption exercise21,828$13.97KForm 4
Nov 12, 2025Shah PratikDirectorGift100,000—Form 4
Nov 12, 2025Shah PratikDirectorGift250,000—Form 4
Nov 12, 2025Chakma JustinChief Business OfficerSale136,380$1.21MForm 4
Nov 12, 2025Chakma JustinChief Business OfficerSale30,000$267.36KForm 4
Nov 12, 2025Chakma JustinChief Business OfficerOption exercise30,000$25.20KForm 4
Aug 21, 2025Lowenthal Richard EPRESIDENT AND CEOSale50,000$724.35KForm 4
Aug 21, 2025Scott Kathleen D.Chief Financial OfficerSale12,500$187.50KForm 4
Aug 21, 2025Scott Kathleen D.Chief Financial OfficerOption exercise12,500$18.75KForm 4
Aug 20, 2025Tanimoto SarinaCHIEF MEDICAL OFFICERSale37,656$530.63KForm 4
Aug 19, 2025Tanimoto SarinaCHIEF MEDICAL OFFICERSale12,344$173.13KForm 4
Jul 1, 2025Karas EricChief Commercial OfficerSale15,000$254.86KForm 4
Jul 1, 2025Karas EricChief Commercial OfficerOption exercise15,000$22.50KForm 4
Jun 27, 2025Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt III, L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Private Design Fund IV, L.P.10% OwnerSale370,074$6.83MForm 4
Jun 27, 2025Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt III, L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Private Design Fund IV, L.P.10% OwnerSale370,075$6.83MForm 4
Jun 18, 2025Karas EricChief Commercial OfficerSale15,000$240.00KForm 4
Jun 18, 2025Karas EricChief Commercial OfficerOption exercise15,000$22.50KForm 4
May 20, 2025Fitzpatrick Alexander AChief Legal OfficerSale102,969$1.45MForm 4
May 20, 2025Fitzpatrick Alexander AChief Legal OfficerOption exercise100,000$558.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related